Baltimore-based AgeneBio announced a pair of grants from the National Institutes of Health that will assist with clinical trials of a treatment to combat the progression of Alzheimer’s disease.
{iframe}https://technical.ly/baltimore/2018/10/11/agenebio-gets-grants-to-advance-therapeutics-to-slow-alzheimers/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=66627723&_hsenc=p2ANqtz-86zS-6pMBrGKAt0MvH2ztuTydOMqF8Zsd4jXB2NdeTwBDYLxb19FKzbyahcj3Cc_L155R3SIa8vsBik3YGLiKdcMXXGw&_hsmi=66627723{/iframe}